Edesa Biotech, Inc. (EDSA): Depreciation & Amortization
$119.3K
Year ended 2025-09-30
$102.8K
Trailing 12 months to 2026-06-30
-2.9%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $119.3K | -35.9% | 2025-12-12, From 2024-10-01 |
| 2024-09-30 | $186.0K | +1.4% | 2025-12-12, From 2023-10-01 |
| 2023-09-30 | $183.5K | n/a | 2024-12-13, From 2022-10-01 |
| No annual figure between 2017-09-30 and 2023-09-30. | |||
| 2017-09-30 | $179.3K | +19.9% | 2017-12-01, From 2016-10-01 |
| 2016-09-30 | $149.6K | -6.2% | 2017-12-01, From 2015-10-01 |
| 2015-09-30 | $159.5K | n/a | 2017-12-01, From 2014-10-01 |
| 2014-08-31 | $158.3K | +26.8% | 2016-12-14, From 2013-09-01 |
| 2013-08-31 | $124.8K | +11.3% | 2015-12-14, From 2012-09-01 |
| 2012-08-31 | $112.1K | n/a | 2014-11-21, From 2011-09-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | 2025-09-30 | $119.3K | -35.9% |
| CytoDyn Inc. (CYDY) | 2026-05-31 | $17.0K | -5.6% |
| Exicure, Inc. (XCUR) | 2025-12-31 | $242.0K | +764.3% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $70.0K | n/m |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $96.1K | n/m |
| Imunon, Inc. (IMNN) | 2024-12-31 | $240.0K | -3.2% |
| Cellectar Biosciences, Inc. (CLRB) | 2025-12-31 | $213.6K | -26.8% |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | $52.7K | +11.1% |
| Aprea Therapeutics, Inc. (APRE) | 2025-12-31 | $21.7K | -2.7% |
Compare EDSA, CYDY, XCUR, NRXP side by side · Screen every company in Pharmaceutical Preparations ↗